EP3459564
Blóðvökva-kallikrein-bindiprótín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.1.2011EP published:
27.10.2021EP application number:
18185298.9
EP translation filed:
27.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
5.1.2031Expiry date:
5.1.2027Next due date:
31.1.2027
Title:
PLASMA KALLIKREIN BINDING PROTEINS
Timeline
Today
6.1.2011EP application
27.10.2021EP Publication
27.1.2022Translation submitted
15.2.2022Registration published
5.1.2027Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
SEXTON, Daniel J.Address:
Melrose, MA 02176, US
Name:
VISWANATHAN, MaliniAddress:
Acton, MA 01720, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
29261410 PDate:
6.1.2010Country:
US
Classification
Categories:
A61K 39/395, C07K 16/18, C07K 16/40
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 17.2.2022
Expires: 5.1.2023
Payer: Patice ehf.
Number: 13
Paid: 22.12.2022
Expires: 5.1.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.12.2023
Expires: 5.1.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 27.12.2024
Expires: 5.1.2026
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.1.2026
Expires: 5.1.2027
Payer: Árnason Faktor ehf.